Back to Search Start Over

Gadolinium-based contrast agent exposures and physical and cognitive disability in multiple sclerosis.

Authors :
Nakamura K
McGinley MP
Jones SE
Lowe MJ
Cohen JA
Ruggieri PM
Ontaneda D
Source :
Journal of neuroimaging : official journal of the American Society of Neuroimaging [J Neuroimaging] 2023 Jan; Vol. 33 (1), pp. 85-93. Date of Electronic Publication: 2022 Oct 01.
Publication Year :
2023

Abstract

Background and Purpose: The clinical correlation of gadolinium-based contrast agents (GBCAs) has not been well studied in multiple sclerosis (MS). We investigated the extent to which the number of GBCA administrations relates to self-reported disability and performance measures.<br />Methods: A cohort of MS patients was analyzed in this retrospective observational study. The main outcome was the association between the cumulative number of GBCA exposures (linear or macrocyclic GBCA), Patient-Determined Disease Steps (PDDS), and measures of physical and cognitive performance (walking speed test, manual dexterity test [MDT], and processing speed test [PST]). The analysis was performed first cross-sectionally and then longitudinally.<br />Results: The cross-sectional data included 1059 MS patients with a mean age of 44.0 years (standard deviation = 11.2). While the contrast ratio in globus pallidus weakly correlated with PDDS, MDT, and PST in a univariate correlational analysis (coefficients, 95% confidence interval [CI] = 0.11 [0.04, 0.18], 0.15 [0.08, 0.21], and -0.16 [-0.10, -0.23], respectively), the associations disappeared after covariate adjustment. A significant association was found between number of linear GBCA administrations and PDDS (coefficient [CI] = -0.131 [-0.196, -0.067]), and MDT associated with macrocyclic GBCA administrations (-0.385 [-0.616, -0.154]), but their signs indicated better outcomes in patients with greater GBCA exposures. The longitudinal data showed no significant detrimental effect of macrocyclic GBCA exposures.<br />Conclusion: No detrimental effects were observed between GBCA exposure and self-reported disability and standardized objective measures of physical and cognitive performance. While several weak associations were found, they indicated benefit on these measures.<br /> (© 2022 The Authors. Journal of Neuroimaging published by Wiley Periodicals LLC on behalf of American Society of Neuroimaging.)

Details

Language :
English
ISSN :
1552-6569
Volume :
33
Issue :
1
Database :
MEDLINE
Journal :
Journal of neuroimaging : official journal of the American Society of Neuroimaging
Publication Type :
Academic Journal
Accession number :
36181666
Full Text :
https://doi.org/10.1111/jon.13057